Terminal2 — Card #67: Pediatric / Congenital Life-Limiting Genetic and Metabolic Disorders

S01 Everyone

What Is It

The spectrum of life-limiting genetic and metabolic conditions in children — from chromosomal disorders to lysosomal storage diseases — and the clinical reality that unites them at the bedside.

Life-Limiting Conditions Prevalence

32 per 10k

Estimated prevalence of life-limiting conditions in children aged 0–19 in the UK — approximately 49,000 children at any time; a rising number as medical advances extend survival without cure.^[6]

Trisomy 18 Live Births

1 in 3,600–6,000

Trisomy 18 (Edwards syndrome) is the second most common autosomal trisomy; median survival 5–15 days without intervention, but 10% reach 1 year and some children survive beyond 10 years with active cardiac and surgical management.^[7]

SMA Type 1 — Leading Genetic Cause of Infant Death

1 in 10k

Spinal muscular atrophy type 1 (Werdnig-Hoffmann disease) was universally fatal by age 2 before gene therapy; nusinersen and onasemnogene abeparvovec have transformed the hospice calculus for SMA type 1.^[57]

Pediatric Deaths Needing Palliative Care

~50,000/yr

In the US, approximately 50,000 children die annually from conditions that would benefit from pediatric palliative care; fewer than half of these children receive any formal palliative care services before death.^[1]

Pediatric life-limiting genetic and metabolic conditions are a heterogeneous group of disorders united by a single clinical reality: they will cause or significantly contribute to the child's death. The spectrum ranges from conditions that are uniformly fatal within hours of birth (anencephaly, thanatophoric dysplasia) to conditions that extend survival into childhood or early adulthood with progressive neurological deterioration (Tay-Sachs disease, Niemann-Pick type C). Between these poles lie the chromosomal aneuploidies — trisomy 13 (Patau syndrome, ~1 in 5,000–12,000 live births) and trisomy 18 (Edwards syndrome, ~1 in 2,500–6,000 live births) — where the historical characterization as "incompatible with life" has been progressively challenged by families who chose cardiac surgery, gastrostomy tube placement, and active medical management, producing children who survived years beyond every prediction.^[7]^[8]

The lysosomal storage disorders — infantile Tay-Sachs (hexosaminidase A deficiency, ~1 in 300,000 general population, 1 in 3,600 Ashkenazi Jewish), Krabbe disease (galactocerebrosidase deficiency, ~1 in 100,000), Niemann-Pick type C (NPC1/NPC2 deficiency), infantile Pompe disease (acid alpha-glucosidase deficiency) — share a common pathophysiology of progressive substrate accumulation causing neuronal destruction, but each presents with a distinct clinical phenotype, a distinct seizure profile, and a distinct timeline that the hospice clinician must know specifically.^[17]^[18] Spinal muscular atrophy type 1 stands apart: once the most common genetic cause of infant death, it has been transformed by disease-modifying therapies (nusinersen, onasemnogene abeparvovec, risdiplam) that have rewritten the natural history — yet families still choose comfort-directed care when the diagnosis is late, when the disease is advanced, or when the treatment burden exceeds the family's tolerance.^[57]

What unites every condition in this card is not the genetics — it is the family. The parent who receives a life-limiting diagnosis for their child — whether at the 20-week anatomy scan, at the newborn screening result, or at the 6-month developmental regression — enters a grief that has no cultural script, no natural order, and no endpoint. The hospice clinician who walks into this encounter walks into the most specific and most demanding human situation in all of palliative medicine. The anticonvulsants must be right. The feeding decision must be held with extraordinary care. The advance directive must account for what happens in the delivery room. And the human skills — the ability to be present with the full weight of a child's death and a parent's grief without looking away — are the foundation everything else is built on.^[1]

🧭 Clinical framing

Every pediatric life-limiting genetic condition generates the same core clinical demands: (1) seizure management that uses non-IV routes (buccal, rectal, intranasal) to spare the infant additional distress; (2) feeding decisions where the act of feeding is also the act of parenting and stopping feels like abandonment; (3) an advance directive architecture that accounts for the spectrum from a birth plan in a prenatally diagnosed condition to end-stage management in a child who has survived years; (4) grief support that begins at diagnosis, not at death, and that addresses the entire family including siblings. The hospice team that masters these four domains can care for any child in this spectrum. The team that misses any one of them will fail the family in a way the family will remember for the rest of their lives.

From the Field

Waldo Rios, NP

Hospice NP · 12+ Years

"The first time you walk into a house where the parents are holding a baby they know is going to die, everything you think you know about hospice resets to zero. The clinical skills are specific — the seizure meds, the feeding plan, the comfort kit — but the human skill is this: you sit down, you use the baby's name, and you do not look away. That is the foundation. Everything else is built on it."

— Waldo, NP · Terminal2

S02Clinician

How It's Diagnosed

Three diagnostic pathways the hospice clinician must understand: prenatal screening, newborn screening, and postnatal clinical recognition.

Prenatal Diagnosis

Cell-free fetal DNA (cfDNA / NIPT): Non-invasive screening of fetal DNA in maternal blood; sensitivity >99% for trisomy 18 and 21; high sensitivity for trisomy 13; a positive cfDNA requires diagnostic confirmation^[7]
Amniocentesis: Gold standard diagnostic confirmation of chromosomal aneuploidy; chromosomal karyotype or chromosomal microarray provides the definitive diagnosis
Prenatal anatomy ultrasound: Characterizes structural anomalies — cardiac defects, brain anomalies, limb anomalies, renal anomalies — forming the clinical basis for prognosis and care planning
Fetal echocardiogram: For conditions with high rates of congenital heart disease (trisomy 13, trisomy 18, DiGeorge syndrome); cardiac anatomy directs postnatal intervention decisions

Newborn Screening (NBS)

Expanded NBS panels: Most US states now detect Pompe disease, SMA, organic acidemias, and fatty acid oxidation disorders on the newborn screening panel^[57]
SMA screening: NBS allows pre-symptomatic gene therapy administration that can prevent symptom onset entirely — transforming a uniformly fatal disease into a treatable condition when caught early
Pompe disease: NBS allows enzyme replacement therapy (ERT) initiation before cardiomyopathy develops, significantly extending survival
Positive NBS result: Triggers urgent metabolic specialty consultation; the hospice clinician must understand that NBS is a screening test — confirmatory testing follows

Postnatal Clinical Diagnosis

Storage disorder presentation: The infant presenting with developmental regression, progressive spasticity, hepatosplenomegaly, or cherry-red spot on fundoscopy undergoes targeted metabolic testing^[17]
Tay-Sachs: Hexosaminidase A enzyme assay from blood leukocytes; the cherry-red macular spot on fundoscopy is the classic clinical finding; developmental regression beginning at 3–6 months
Krabbe disease: Galactocerebrosidase (GALC) enzyme assay from leukocytes or fibroblasts; CSF protein elevation; MRI showing white matter demyelination; extreme irritability as the earliest clinical sign^[18]
Niemann-Pick type C: Filipin staining of cultured fibroblasts (gold standard); oxysterol panel as screening; NPC1/NPC2 gene sequencing; vertical supranuclear gaze palsy as the classic clinical sign^[19]
SMA type 1: SMN1 gene deletion testing; symmetric proximal weakness, absent deep tendon reflexes, tongue fasciculations, paradoxical breathing pattern (bell-shaped chest, diaphragmatic breathing)

💡 For families

Most of the diagnostic testing is already complete by the time your child enters hospice care. The diagnosis has been confirmed. The focus now shifts entirely to your child's comfort, your family's support, and making sure every moment together is as peaceful as possible. If you have questions about the diagnosis or the tests that were done, your hospice team can explain them in plain language — please ask.

S03Everyone

Causes & Risk Factors

Pathogenesis of each condition and the clinical relevance for comfort management. Understanding why these conditions cause the symptoms they cause changes how you manage them.

Chromosomal Aneuploidies — Trisomy 13 & 18

Mechanism: Meiotic non-disjunction producing an extra copy of chromosome 13 or 18; risk increases with maternal age (same mechanism as trisomy 21)^[7]
Trisomy 13: Holoprosencephaly (failure of prosencephalon to divide — producing midline brain and facial defects); congenital heart disease in ~80% (ASD, VSD, HLHS); polydactyly; cutaneous aplasia; renal anomalies; the holoprosencephaly produces central apnea, temperature dysregulation, and seizures
Trisomy 18: Characteristic clenched hand deformity (overlapping fingers); congenital heart disease in ~95% (the cardiac defect is the most common cause of death); brain malformations (choroid plexus cysts, ACC, Dandy-Walker); central apnea from brain malformation^[8]
Comfort relevance: The cardiac defect produces cyanosis and heart failure — primary sources of comfort distress; central apnea produces respiratory distress; feeding intolerance from neurological oromotor dysfunction is universal

Lysosomal Storage Disorders

Tay-Sachs: Autosomal recessive deficiency of hexosaminidase A; GM2 ganglioside accumulates in neurons causing progressive neuronal death; the myoclonic seizures and hyperekplexia (startle response) are specific to the GM2 accumulation pattern; carrier frequency 1 in 30 in Ashkenazi Jewish populations^[17]
Krabbe disease: Autosomal recessive deficiency of galactocerebrosidase; psychosine accumulates causing oligodendrocyte death and demyelination; the extreme irritability is the hallmark early symptom — caused by demyelination-induced neuropathic pain^[18]
Niemann-Pick type C: Autosomal recessive NPC1/NPC2 mutations; cholesterol trafficking defect causes lipid accumulation; vertical supranuclear gaze palsy, progressive ataxia, cognitive decline, hepatosplenomegaly^[19]
Pompe disease: Autosomal recessive acid alpha-glucosidase (GAA) deficiency; glycogen accumulates in cardiac and skeletal muscle; infantile form presents with severe cardiomyopathy, hypotonia, macroglossia

Spinal Muscular Atrophy & Neuromuscular

SMA type 1: Autosomal recessive; homozygous SMN1 gene deletion; motor neurons in the anterior horn of the spinal cord degenerate; progressive symmetric proximal weakness; respiratory failure is the cause of death^[57]
Comfort relevance: Cognition is fully preserved — the child is alert, aware, and responsive even as motor function deteriorates completely; this preserved cognition creates the unique clinical and emotional landscape of SMA type 1 palliative care
Gene therapy era: Nusinersen (Spinraza), onasemnogene abeparvovec (Zolgensma), and risdiplam (Evrysdi) have transformed SMA type 1 when administered early; the hospice calculus now includes children for whom treatment was late, failed, or was declined

Lethal Skeletal & Neural Tube Defects

Anencephaly: Neural tube defect — failure of anterior neural tube closure; absence of cerebral hemispheres and calvarium; brainstem reflexes may be present; survival is measured in hours to days; folic acid supplementation reduces risk by 50–70%^[1]
Thanatophoric dysplasia: FGFR3 mutation; the most common lethal skeletal dysplasia; severely shortened limbs, narrow thorax producing pulmonary hypoplasia; respiratory failure is the cause of death, typically within hours to days
Comfort relevance: These conditions are typically diagnosed prenatally; perinatal palliative care begins before birth; the birth plan is the primary clinical document

❤️ For families: "Why did this happen?"

This is not your fault. Chromosomal conditions like trisomy 13 and trisomy 18 happen because of a random error in cell division — it is not caused by anything either parent did or did not do during pregnancy. The metabolic conditions (Tay-Sachs, Krabbe, SMA) are inherited — both parents carry one copy of a changed gene without knowing it. Carrier status is common and was invisible until the diagnosis. There is no blame here. There is a child who needs care, and a family that deserves support.

⚕ Clinician note: Genetic counseling at hospice enrollment

Even at hospice enrollment, referral for genetic counseling is appropriate and clinically important for autosomal recessive conditions (Tay-Sachs, Krabbe, SMA, Pompe). Recurrence risk is 25% for each subsequent pregnancy. Carrier testing for siblings and extended family members can identify at-risk relatives. Preimplantation genetic diagnosis (PGD) is available for future pregnancies. The genetic counseling conversation is not about the dying child — it is about the family's future reproductive decisions, and it belongs in the hospice plan of care.^[61]

S04ClinicianEveryone

Treatments & Procedures

The comprehensive pediatric comfort management framework: seizures, feeding, respiratory, pain, cardiac, GI, spasticity, and end-of-life symptom control.

Comfort management in pediatric life-limiting genetic conditions requires disease-specific and age-specific pharmacology. The anticonvulsant selection, the route of administration, the feeding decision framework, and the respiratory management all differ fundamentally from adult hospice care. Every medication decision must account for the immature hepatic and renal systems of infants, the specific seizure type produced by each genetic condition, and the non-IV routes that spare the infant the additional distress of venipuncture and IV access.^[25]

Seizure Management — The Most Technically Specific Comfort Intervention

Anticonvulsant Selection by Disease

Tay-Sachs myoclonic seizures: Clonazepam 0.01–0.05 mg/kg/day divided BID-TID — the most effective agent for the myoclonic seizures and hyperekplexia of Tay-Sachs; valproic acid 20–40 mg/kg/day for complex partial and generalized tonic-clonic seizures^[25]
Infantile spasms (any cause): Vigabatrin 50–150 mg/kg/day divided BID — more compatible with the home comfort setting than ACTH; avoids the hospitalization and monitoring burden of ACTH protocol^[28]
Trisomy 13/18 seizures: Phenobarbital in the neonatal period (IV/IM availability, long duration); levetiracetam increasingly used for low sedation burden and broad-spectrum efficacy^[26]
Krabbe disease: Clonazepam for irritability and myoclonus; gabapentin for neuropathic pain component; levetiracetam for generalized seizures

Home Seizure Rescue Protocol

Buccal midazolam: 0.3 mg/kg (max 10 mg) — place syringe between cheek and lower gum; half dose each side; onset 3–5 minutes; the preferred home rescue from family acceptance and comfort^[22]
Rectal diazepam: 0.5 mg/kg (max 20 mg) via rectal gel (Diastat); the established pediatric seizure rescue with extensive safety data^[24]
Intranasal midazolam: 0.2 mg/kg using concentrated solution (5 mg/mL) via mucosal atomization device (MAD); rapid onset; useful when buccal route is not available^[29]
Protocol: Seizure >3–5 min → administer rescue med → call hospice nurse → if seizure continues 10 min → repeat dose or activate advance directive instructions

Feeding Decision Framework

Comfort Oral Feeding

The clinical prescription: Small amounts of formula or breast milk offered for comfort, connection, and parenting — not for nutrition; aspiration risk acknowledged and accepted by the family as an informed comfort choice^[32]
The parenting act: Feeding is not merely a medical act in infancy — it is the primary way parents bond with their baby; stopping oral feeding feels like abandonment; the clinical team must validate comfort oral feeding as a legitimate care choice
Technique: Small volumes (5–15 mL); slow pacing; upright positioning; oral care with breast milk on gauze for infants who cannot swallow safely; stop if the infant shows distress

Gastrostomy & GI Management

Gastrostomy tube: When present, provides nutrition and hydration while comfort oral feeding provides connection; medication administration route that avoids oral medication battles
GERD management: Omeprazole 1 mg/kg/day divided BID — the PPI at twice-daily dosing confirmed or initiated at enrollment; GERD is universal in neurologically impaired infants^[33]
Constipation: Polyethylene glycol (MiraLAX) 0.5–1 g/kg/day — the osmotic laxative that is safe and effective in infants >6 months; glycerin suppositories for infants <6 months

Respiratory, Pain, Cardiac & Spasticity Management

Respiratory Comfort

Central apnea: Positioning (elevated HOB 30°); monitoring for parental reassurance; caffeine citrate in neonatal period if consistent with goals; apnea alarms at family's discretion
Secretion management: Glycopyrrolate 40–100 mcg/kg/day divided TID-QID — the anticholinergic that reduces secretions without CNS sedation; preferred over atropine^[43]
Dyspnea: Low-dose morphine 0.05–0.1 mg/kg PO/SQ q4h — pre-prescribed before any acute respiratory event; the morphine that is not available when the first respiratory crisis occurs is a clinical failure

Pain, Cardiac & Spasticity

Pain assessment: FLACC scale (Face, Legs, Activity, Cry, Consolability) for infants and young children; N-PASS for neonates; behavioral distress is pain until proven otherwise^[38]
Confirmed pain: Morphine 0.05–0.1 mg/kg PO/SQ q4h; acetaminophen 15 mg/kg q4–6h for mild pain; ibuprofen 5–10 mg/kg q6–8h if >6 months with adequate renal function
Spasticity: Baclofen 5 mg PO TID (children >2 yr), titrate; diazepam 0.1–0.3 mg/kg TID for acute spasticity; botulinum toxin for focal spasticity causing positioning difficulty
Heart failure: Furosemide 1–2 mg/kg/dose BID for fluid overload; low-dose morphine for dyspnea from cardiac failure; digoxin only if already established and consistent with comfort goals

End-of-Life Symptom Management

Terminal seizure management: When seizures become refractory to oral/enteral anticonvulsants, the combination of continuous subcutaneous midazolam infusion (0.05–0.1 mg/kg/hour) plus phenobarbital loading (15–20 mg/kg IV or IM followed by maintenance 3–5 mg/kg/day) provides seizure control with acceptable sedation at end of life. The goal shifts from seizure freedom to seizure comfort — the family must understand that some seizure activity may persist but that the child's distress is managed.^[30]

Terminal respiratory distress: Morphine continuous infusion 0.01–0.04 mg/kg/hour SQ or IV; glycopyrrolate for secretions; gentle suctioning only when visible and distressing; the family must be prepared for changes in breathing pattern (Cheyne-Stokes, agonal breathing) before they occur.^[43]

Palliative sedation: When symptoms are refractory to all standard measures and the child is in the final hours to days, palliative sedation with midazolam ± phenobarbital is ethically appropriate and clinically indicated. Document the clinical reasoning, the goals-of-care discussion, and the family's informed consent. Palliative sedation is not euthanasia — it is symptom management for refractory suffering.^[44]

S05Clinician

When Therapy Makes Sense

Enrollment checklist — the non-negotiable clinical acts that must be completed before the first crisis occurs.

In pediatric life-limiting conditions, "when therapy makes sense" is reframed: every item below is a clinical act that must be completed at enrollment — not at a later visit, not at the first crisis. The rescue seizure medication that is not in the home when the first seizure occurs is a clinical failure. The birth plan that is not completed before delivery is a clinical failure. The sibling who is watching their parent cry and has received no support is a clinical failure.^[1]

01
Rescue seizure protocol prescribed and in the home at enrollment: Rectal diazepam AND buccal midazolam prescriptions written, supplies in the home, family trained in both techniques, written instructions posted in the home. The seizure that requires an ED visit for IV access when a home rescue protocol would have managed it is a comfort failure.^[22]
02
Comfort feeding approach established at enrollment: The explicit discussion of the comfort oral feeding framework; the parental informed consent for comfort oral feeding with acknowledged aspiration risk documented; the PPI for GERD at twice-daily dosing confirmed or initiated; gastrostomy management protocol established if a gastrostomy is present.^[32]
03
Birth plan completed and distributed for prenatally diagnosed conditions: Every element documented before delivery — who holds the baby first, resuscitation preferences, comfort medications available in the delivery room, memory-making plan, chaplain/spiritual care availability, sibling visit plan, photography consent.^[46]
04
Pain and discomfort behavioral assessment protocol established at enrollment: FLACC or N-PASS or CRIES scale used at every clinical encounter; the caregiver's behavioral comfort indicators documented as the individual comfort assessment standard for this specific child; "Tell me what it looks like when the baby is uncomfortable."^[38]
05
Low-dose morphine available and pre-prescribed before any acute respiratory event: Not prescribed in the emergency department during the first respiratory crisis; written before the crisis occurs. Morphine 0.05–0.1 mg/kg PO/SQ q4h PRN for dyspnea or pain — available in the home on day one.^[43]
06
Advance directive completed at enrollment: Resuscitation status, intubation preference, hospitalization preference, seizure management approach (comfort-only versus emergency transport for status epilepticus), NIV preference, and the specific decisions relevant to the underlying condition.^[1]
07
Sibling support resources facilitated at enrollment — not at a later visit: The 3-year-old sibling who is watching their parent cry deserves a clinical response at enrollment. Age-appropriate grief resources, child life specialist referral, sibling-specific counseling — before the death, not after.^[53]
08
Memory-making offered at enrollment: Professional photography (Now I Lay Me Down to Sleep), handprints and footprints, hair clippings, recordings of heartbeat, blankets and clothing that carry the baby's scent — offered proactively, not waiting for the family to ask, because most families do not know to ask until it is too late.^[55]
09
Extended family communication plan documented: What does the family want to tell grandparents, great-grandparents, friends, faith community? Who needs to be contacted? What language does the family want used? The clinical team can facilitate this communication — do not leave it to the grieving parents alone.
10
Genetic counseling referral initiated at enrollment for autosomal recessive conditions: Recurrence risk counseling, carrier testing for family members, and future reproductive options (PGD, prenatal diagnosis) — these conversations belong in the hospice plan of care because they affect the family's future.^[61]

S06Clinician

When It Doesn't

Thresholds where interventions cause harm — the specific clinical situations in pediatric palliative care where more is worse.

In pediatric life-limiting conditions, the threshold between helpful and harmful is specific, measurable, and often crossed with good intentions. The parent who pushes formula into a gagging infant is acting from love. The clinician who sends a comfort-directed child to the emergency department for a seizure the rescue protocol could have managed is acting from fear. Both need the clinical team to name the threshold clearly, before it is crossed.^[1]

01
Framing any condition as "incompatible with life" in clinical conversation: This language has been used to discourage intervention and has been challenged by the survival of children who exceeded its predictions. Clinical communication must hold the prognostic data ("most children with trisomy 18 die in the first weeks of life") alongside the uncertainty ("some children have survived much longer, and we cannot predict which outcome will apply to your daughter") without foreclosing the family's hope or their choice.^[10]
02
ED visits for seizures when a home rescue protocol exists: The emergency department visit for a seizure in a child with a known life-limiting condition and a rescue protocol available at home adds suffering without clinical benefit — fluorescent lights, separation from parents, IV access, unfamiliar providers. The rescue protocol prevents this. If the family is calling 911 for seizures, the rescue protocol training has failed and must be repeated.^[22]
03
Aggressive feeding beyond what the child can safely manage: The parent who is pushing formula into an infant with oropharyngeal dysmotility — watching the infant gag and aspirate — because stopping feels like abandonment, needs the clinical team to validate comfort oral feeding (small amounts for pleasure) while naming the fact that stopping unsafe oral feeding is not abandonment but protection.^[32]
04
Assuming a non-verbal infant cannot feel pain or discomfort: The infant with trisomy 18 who is crying and arching has a behavioral pain profile that requires assessment and treatment. Behavioral distress in a non-verbal infant is pain until proven otherwise. The FLACC scale exists for this purpose — use it at every visit.^[38]
05
Withholding opioids from infants and young children from fear of respiratory depression: Morphine at appropriate pediatric doses (0.05–0.1 mg/kg) is safe and indicated for dyspnea and pain in infants with life-limiting conditions. The fear of respiratory depression that prevents adequate pain management in a dying child is a clinical failure rooted in myth, not evidence.^[43]
06
Delaying memory-making until "later": There may not be a later. The infant with anencephaly may live hours. The baby with trisomy 18 may die before the photographer arrives. Offer handprints, footprints, professional photography, and other memory-making at the first encounter — not the third.^[55]
07
Ignoring the siblings: The 3-year-old who is watching their parent sob, who is being shuttled to grandparents' houses, who is told "the baby is sick" without context or support — this child will carry this experience into adulthood. Sibling grief assessment and support at enrollment is a clinical requirement, not an optional add-on.^[53]
08
Pursuing disease-directed therapy when the treatment burden exceeds the family's tolerance: The SMA type 1 infant receiving nusinersen intrathecal injections every 4 months in a hospital setting when the family has chosen comfort-directed care — the treatment may extend survival but if it adds hospital visits, sedation, and distress in a child whose family wants only home time, the treatment is causing net harm.

📋 Clinician note

The false binary of "treatment vs. comfort" is especially destructive in pediatric palliative care. Families who choose comfort-directed care for their child are not "giving up" — they are making a decision that prioritizes their child's experience of life over the duration of life. Name this explicitly. The language is: "You are not giving up on your child. You are choosing to protect your child from suffering. That is the most powerful act of love a parent can perform."

S07Everyone

Out-of-the-Box Approaches

Evidence-graded integrative and innovative approaches specific to pediatric life-limiting conditions. Grade A = RCT; B = multi-observational/meta-analysis; C = limited clinical; D = expert opinion.

Buccal Midazolam — Preferred Home Seizure Rescue

Grade A

Buccal midazolam 0.3 mg/kg (max 10 mg) via syringe between cheek and lower gum; onset 3–5 min

Scott et al. (1999, Lancet) published the landmark RCT demonstrating buccal midazolam is as effective as rectal diazepam for acute seizure termination in children, with faster family acceptance. McMullan et al. (2010, Lancet) confirmed superiority of buccal midazolam over rectal diazepam for prolonged seizures. The buccal route provides: reliable mucosal bioavailability; onset comparable to rectal diazepam; greater dignity (no undressing required); compatibility with public settings. In the hospice home, buccal midazolam eliminates the need for ED visits for seizure management. Prescribe at enrollment alongside rectal diazepam — both medications available, both techniques trained.^[22]^[23]

Comfort Oral Feeding Framework

Grade A

Small volumes (5–15 mL) of formula/breast milk offered for comfort and connection; upright positioning; stop if distress

The clinical evidence from advanced dementia palliative care (Palecek et al. 2010), from dysphagia management in neurological disease, and from pediatric palliative care specifically supports comfort oral feeding as a legitimate and beneficial clinical prescription. The framework separates the nutritional act (provided by gastrostomy when present) from the parenting and comfort act (provided by careful oral feeding). The aspiration risk is acknowledged, discussed with the family, and accepted as part of an informed comfort choice. The parent who can offer small amounts by mouth — feeling the baby suck, providing that closeness — reports psychological benefit that is clinically significant. The clinical prescription is: "You may offer small amounts by mouth for comfort and connection. This is not nutrition — it is care."^[32]

Intranasal Midazolam

Grade B

Intranasal midazolam 0.2 mg/kg via MAD (mucosal atomization device); concentrated 5 mg/mL solution; max 0.3 mL per nostril

Multiple observational studies and pharmacokinetic analyses demonstrate that intranasal midazolam achieves therapeutic serum levels within 3–5 minutes via the highly vascular nasal mucosa. The mucosal atomization device (MAD) converts the liquid to a fine mist that maximizes mucosal absorption. Particularly useful for the infant or child who is actively seizing and whose jaw is clenched (making buccal administration difficult). The concentrated 5 mg/mL solution minimizes volume — critical for nasal administration. Available as a third rescue option alongside buccal and rectal routes.^[29]

Perinatal Palliative Care

Grade B

Structured perinatal palliative care program beginning at prenatal diagnosis; birth plan; delivery room comfort management

Leuthner, Breeze & Lees, Catlin, and Janvier have established the evidence base for structured perinatal palliative care programs that begin at prenatal diagnosis and continue through delivery, neonatal care, death, and bereavement. Wool (2013) provided a systematic review documenting improved family outcomes with structured perinatal palliative care. The birth plan as clinical document — specifying who holds the baby first, resuscitation preferences, comfort medications, memory-making, spiritual care — improves family satisfaction and reduces complicated grief. Perinatal palliative care is now considered standard of care for prenatally diagnosed life-limiting conditions.^[46]^[47]^[48]

Vigabatrin for Infantile Spasms in Comfort Setting

Grade A

Vigabatrin 50–150 mg/kg/day divided BID; oral solution; titrate over 1–2 weeks

The UKISS trial (Lux et al. 2005) and the Infantile Spasms Working Group guidelines established vigabatrin as first-line or second-line for infantile spasms. In the comfort care setting, vigabatrin offers advantages over ACTH: oral administration (no injections), home-based initiation (no hospitalization required), lower monitoring burden. The retinal toxicity risk (visual field constriction) that limits long-term vigabatrin use in other populations is clinically irrelevant in a child with a life-limiting condition and a limited life expectancy. Vigabatrin provides effective spasm control compatible with the home comfort setting.^[28]

Music Therapy

Grade B

Live or recorded music therapy; 20–30 min sessions; adapted to infant/child developmental level and condition

Multiple observational studies in pediatric palliative care demonstrate that music therapy reduces behavioral indicators of pain and distress in infants and young children with neurological conditions, reduces parental anxiety, and provides a shared experience between parent and child that transcends the limitations of the child's condition. The infant with Tay-Sachs who can no longer track visually may still respond to music. The parent who sings to their dying child is performing an act of connection that has both emotional and physiological significance. Board-certified music therapists (MT-BC) can be integrated into the hospice plan of care.

S08Everyone

Natural & Herbal Options

The most constrained supplement safety landscape in all of hospice — immature organ systems, anticonvulsant interactions, and the emotional context of a parent trying everything they can.

From the Field

Waldo Rios, NP

Hospice NP · 12+ Years

"When a parent asks about supplements for their child with a life-limiting condition, they are not asking a pharmacology question. They are asking: 'Is there anything I can do?' The answer is always yes — but it must be honest. What is safe, what interacts with the seizure meds, and what the evidence actually shows. The dismissive response — 'supplements won't help' — adds to the grief of parents who are trying everything they can. Engage with what is safe. Honor the motivation."

— Waldo, NP

⚠ Pediatric Supplement Safety — Three Critical Constraints

(1) Immature organ systems: Hepatic enzyme maturation is incomplete in neonates and young infants — dramatically different drug and supplement metabolism than in adults. What is safe in an adult may produce unexpected effects in a 3-month-old. (2) Anticonvulsant interactions: Many supplements interact with antiepileptic medications that are cornerstone comfort management in these conditions; supplements that alter anticonvulsant levels can produce breakthrough seizures or toxicity. (3) Emotional context: Parents seeking supplements are exercising agency and care that the disease is taking from them — this motivation deserves clinical respect and honest engagement. The guiding principle: evaluate every supplement against the specific child's age, weight, anticonvulsant regimen, and underlying metabolic condition.

Supplement	Evidence Grade	Typical Dose	Potential Benefit	⚠ Interactions / Contraindications
Omega-3 (DHA/EPA)	Grade C	DHA 100–200 mg/day liquid formulation (infant); 200–500 mg/day (child)	DHA is a structural component of the developing brain; provided in breast milk; theoretical neuroprotective benefit; anti-inflammatory properties may reduce neuroinflammation in storage disorders	Generally safe at recommended doses; may increase bleeding risk at high doses — monitor if child is on anticoagulants; fish oil liquid formulations may cause GI upset; choose triglyceride-form for better absorption
Vitamin D3	Grade B	400 IU/day (infant); 600–1000 IU/day (child); liquid drops	Deficiency is common in children with limited sun exposure and neurological conditions; adequate vitamin D supports bone health, immune function; children on anticonvulsants (phenobarbital, phenytoin) have increased vitamin D metabolism	Safe at recommended doses; anticonvulsant-induced vitamin D deficiency is well-documented — supplementation is standard of care for children on phenobarbital or phenytoin; monitor 25-OH vitamin D levels annually if feasible^[25]
Probiotics	Grade C	Lactobacillus rhamnosus GG or Bifidobacterium infantis; age-appropriate dose per product	May reduce antibiotic-associated diarrhea; may improve GI comfort in children with dysmotility; breast milk contains natural probiotics	Avoid in immunocompromised children or those with central venous catheters — rare risk of bacteremia; generally safe in immune-competent infants and children; choose products with established pediatric safety data
MCT Oil	Grade C	0.5–1 mL/kg/day added to feeds; titrate slowly	Medium-chain triglycerides bypass the lymphatic system for direct hepatic metabolism; may provide caloric supplementation in children with feeding difficulties; ketogenic diet component for seizure management	May cause GI cramping and diarrhea if introduced too rapidly; start low and titrate; caution in children with hepatic dysfunction; theoretical benefit in seizure management via ketone body production
CBD (Cannabidiol)	Grade C	Epidiolex (prescription CBD): 2.5–5 mg/kg BID; OTC CBD: variable quality — not recommended without pharmacist review	FDA-approved (Epidiolex) for Lennox-Gastaut and Dravet syndrome; may reduce seizure frequency in refractory epilepsy; potential anxiolytic effect	⚠ CYP3A4 and CYP2C19 interactions — increases levels of clobazam, valproic acid, and other anticonvulsants; hepatotoxicity risk especially with concurrent valproic acid; requires LFT monitoring; OTC CBD products have unreliable dosing and purity — use only pharmaceutical-grade product
Chamomile	Grade D	Chamomile tea (diluted) for older infants >6 months; topical chamomile oil for massage	Traditional use for colic, irritability, and sleep; limited evidence for GI soothing; chamomile oil massage may provide comfort through touch and scent	Allergic reactions possible in children with ragweed allergy; avoid concentrated essential oils in infants — dilute appropriately; oral chamomile may have mild sedative effect — monitor with concurrent sedating medications
Melatonin	Grade B	0.5–3 mg PO at bedtime; start at lowest dose; liquid formulation available	Well-studied in children with neurological conditions for sleep-wake cycle regulation; may reduce time to sleep onset; particularly useful in children with circadian rhythm disruption from neurological disease	Generally safe at recommended doses; may interact with immunosuppressants; may lower seizure threshold at high doses in some reports — start low; choose pharmaceutical-grade product without additives

🚫 Avoid in Pediatric Life-Limiting Conditions

St. John's Wort (Hypericum): Potent CYP3A4 inducer — reduces levels of virtually all anticonvulsants (phenobarbital, carbamazepine, levetiracetam, clobazam); can cause breakthrough seizures; contraindicated with any anticonvulsant regimen
Kava (Piper methysticum): Hepatotoxic — contraindicated in infants and young children with immature hepatic systems; sedation compounds anticonvulsant sedation; no pediatric safety data
Valerian root: GABAergic mechanism — unpredictable interaction with benzodiazepines and barbiturates; may compound sedation; no pediatric dosing data; avoid in children on clonazepam, diazepam, or phenobarbital
Ephedra (Ma Huang): Sympathomimetic — increases heart rate and blood pressure; contraindicated in children with congenital heart disease (trisomy 13, trisomy 18, Pompe); proconvulsant risk; banned by FDA in dietary supplements but available in some herbal formulations
Ginkgo biloba: Antiplatelet effect — increases bleeding risk; may lower seizure threshold; no pediatric safety data in this population; avoid

S09Everyone

Timeline Guide

A five-phase pediatric timeline — from prenatal diagnosis through the final hours. Not a prediction — a framework for preparation. Every child's trajectory is unique.

The timeline in pediatric life-limiting genetic conditions is more heterogeneous than any other card in this series — it spans from hours (anencephaly, severe thanatophoric dysplasia) to years (some trisomy 18 with intervention, Tay-Sachs, SMA type 1 with gene therapy). This 5-phase framework addresses the multiple trajectories simultaneously. Not every child will pass through every phase. Some will move from Phase 1 directly to Phase 5. The framework prepares the family and the clinical team for what may come — without predicting which path any individual child will follow.^[1]^[7]

PRE-
NATAL

Phase 1 — Prenatal: Perinatal Palliative Care Begins Before Birth

The prenatal diagnosis at the anatomy scan or after amniocentesis — parents sitting in the maternal-fetal medicine office receiving the diagnosis; the internet searches at 2 AM; the genetic counseling appointment; the cardiologist appointment for the cardiac defect; the first meeting with the neonatologist and the palliative care team^[46]
The decision about the pregnancy — continue or not; for those who continue: the weeks of pregnancy with the name chosen, the nursery partially prepared, the preparation for a baby who may live hours or years
The birth plan conversation: who holds the baby first; resuscitation preferences; comfort medications in the delivery room; memory-making plan (photography, handprints); spiritual care availability; sibling visit plan^[48]
Connection with the community of other families: Trisomy 18 Foundation, Trisomy 13 Foundation, SOFT (Support Organization for Trisomy); these families offer experiential knowledge that no clinician can provide
Clinical priorities: Complete the birth plan; prescribe comfort medications for delivery room; identify the neonatology and palliative care team; advance directive for neonatal period; chaplain/spiritual care identified; memory-making resources arranged

BIRTH
NICU

Phase 2 — Birth & Neonatal Period: The First Hours and Days

The delivery room — the birth plan activated; the clinical team who knows the name and the plan; the parents hold the baby first; the hospice nurse or palliative care team present or immediately available; comfort medications available before the first sign of respiratory distress^[46]
For some infants (anencephaly, severe thanatophoric dysplasia), these are the only hours — memory-making happens in this window: photographs, handprints, footprints, skin-to-skin contact, siblings and grandparents visit, chaplain performs blessing or baptism
For infants who survive days to weeks (trisomy 13, trisomy 18): transition to home or to a dedicated comfort suite in the hospital organized around family presence rather than clinical monitoring; the shift from NICU to comfort care is a specific and deliberate clinical act^[7]
Comfort medications initiated: morphine for respiratory distress or pain; glycopyrrolate for secretions; rescue seizure medications dispensed to the home before discharge; feeding plan established
Clinical priorities: Activate birth plan; memory-making in first hours; establish feeding approach; prescribe comfort kit; home discharge planning if infant survives beyond days; sibling visits facilitated

MOS–
YRS

Phase 3 — Infancy & Early Childhood: The Living Time

For children who survive the neonatal period — trisomy 18 children with cardiac intervention, Tay-Sachs infants in the early developmental phase, SMA type 1 children on gene therapy or choosing comfort care — this phase may last months to years^[17]
Tay-Sachs: the period of normal or near-normal development (first 3–6 months) followed by progressive developmental regression — loss of head control, loss of visual tracking, onset of seizures, increasing feeding difficulty; the parents watch their child lose every skill they gained
Krabbe disease: extreme irritability as the earliest symptom (demyelination-induced neuropathic pain); progressive spasticity; loss of motor milestones; increasing feeding difficulty^[18]
SMA type 1 (comfort care): progressive weakness; preserved cognition and social smile; respiratory function declining; feeding becoming progressively difficult; the child who cannot move but who tracks the parent's face with their eyes
Trisomy 13/18 with intervention: cardiac surgery survivors; gastrostomy-fed; some children developing social responses, showing preferences, interacting with family in ways that exceed every prognostic prediction
Clinical priorities: Seizure management optimization; feeding plan refinement; respiratory support decisions (NIV vs. comfort only); caregiver support and respite; developmental engagement within the child's capacity; ongoing advance directive revision as the child's status changes

WKS–
MOS

Phase 4 — Progressive Decline: The Transition

Seizures increasing in frequency and severity; anticonvulsant doses escalating; rescue medication use increasing; the seizure burden is the primary family distress in storage disorders^[25]
Feeding becomes progressively unsafe — increased aspiration; weight loss despite adequate caloric delivery via gastrostomy; the oral feeding that was safe at 6 months is no longer safe at 18 months; the conversation about reducing or stopping oral feeding
Respiratory function declining — increased secretions; more frequent apneic episodes; desaturation events; the decision about NIV vs. comfort-only respiratory management revisited
Spasticity and positioning become increasingly difficult; the child who could be held comfortably at 6 months requires specific positioning at 18 months; the parent who cannot hold their child the way they used to
Clinical priorities: Escalate anticonvulsant regimen; prepare for refractory seizure management; establish continuous infusion protocols; intensify caregiver support; increase visit frequency; begin explicit final-hours preparation with the family; review and confirm advance directive; ensure all memory-making is complete

HRS–
DAYS

Phase 5 — Final Hours: The Death of a Child

Breathing pattern changes — Cheyne-Stokes respiration; central apnea becoming more prolonged; agonal breathing; the parents have been prepared for these changes and know they indicate the body is shutting down, not that the child is suffering^[43]
Mottling of extremities; peripheral cooling; decreased urine output; the child is minimally responsive or unresponsive; auditory awareness may persist — the parents should continue to talk, sing, and touch
Seizure management: continuous subcutaneous midazolam infusion if seizures are ongoing; the goal is comfort, not seizure freedom; the family understands that some movement may persist and is not suffering
The parents hold the child; skin-to-skin if possible; siblings present if the family chooses; the room is quiet, warm, and familiar; the hospice nurse is present or immediately available; the chaplain is available^[55]
After death: no rush; the family holds the child as long as they need; bathing and dressing the child together; more photographs and handprints; the lock of hair; the chaplain's prayer; the siblings' goodbye; the grandparents' farewell
Clinical priorities: Comfort medications optimized; family supported continuously; memory-making facilitated; death pronounced with dignity and gentleness; bereavement follow-up plan established; the call to the family at 48 hours, 2 weeks, and the anniversary

S10Clinician

Medications to Anticipate

Pediatric-specific pharmacology for life-limiting genetic conditions. Every medication is weight-based, route-specific, and disease-adapted.

🚨 Five Non-Negotiable Clinical Acts at Enrollment

(1) HOME RESCUE SEIZURE PROTOCOL PRESCRIBED AT ENROLLMENT — rectal diazepam and buccal midazolam with written instructions; no ED visit for a seizure the rescue protocol could manage. (2) PAIN AND COMFORT ASSESSMENT SCALE ESTABLISHED — FLACC for infants; caregiver behavioral indicators documented; behavioral distress treated as pain until proven otherwise. (3) LOW-DOSE MORPHINE AVAILABLE AND PRE-PRESCRIBED BEFORE ANY DYSPNEA EVENT — not prescribed at the ED during the first respiratory crisis. (4) BIRTH PLAN COMPLETED AND DISTRIBUTED BEFORE DELIVERY for prenatally diagnosed conditions. (5) COMFORT ORAL FEEDING INFORMED CONSENT DOCUMENTED — the parenting act honored alongside the medical act.

Drug	Class / Target Symptom	Starting Dose	Notes / Cautions
Clonazepam	Benzodiazepine / Myoclonic seizures	0.01–0.05 mg/kg/day divided BID-TID PO/GT	First-line for Tay-Sachs myoclonic seizures and hyperekplexia; liquid formulation available (0.1 mg/mL); also useful for Krabbe irritability; titrate slowly for sedation monitoring.^[25]
Levetiracetam	Anticonvulsant / Broad-spectrum seizures	10–60 mg/kg/day divided BID PO/GT/IV	First-line in many pediatric palliative care programs; broad-spectrum efficacy; low sedation burden; liquid oral solution (100 mg/mL) compatible with GT; IV available for acute management.^[26]
Phenobarbital	Barbiturate / Neonatal seizures	Loading: 15–20 mg/kg IV/IM; Maintenance: 3–5 mg/kg/day	Standard neonatal anticonvulsant; long half-life (40–200 hrs in neonates); available IV, IM, PO; causes sedation — this is an advantage at end of life and a disadvantage in the child with preserved interactive capacity. ⚠ Increases vitamin D metabolism — supplement vitamin D^[25]
Vigabatrin	Anticonvulsant / Infantile spasms	50–150 mg/kg/day divided BID PO	First-line for infantile spasms in comfort setting; avoids ACTH hospitalization burden; retinal toxicity risk irrelevant in limited life expectancy; oral solution available; titrate over 1–2 weeks.^[28]
Valproic Acid	Anticonvulsant / Complex partial & GTC seizures	20–40 mg/kg/day divided BID-TID PO/GT	Effective for Tay-Sachs complex partial seizures; liquid formulation available; monitor LFTs (baseline and periodic); ⚠ Contraindicated in mitochondrial disease (POLG mutations) — hepatotoxicity risk; avoid concurrent CBD — hepatotoxicity
Buccal Midazolam	Benzodiazepine / Seizure rescue	0.3 mg/kg buccal (max 10 mg); compounded 2.5–5 mg/mL solution	Home rescue seizure medication — administer between cheek and lower gum; half dose each side; onset 3–5 min; may repeat once after 10 min. Prescribe at enrollment. Train family. Post instructions.^[22]
Rectal Diazepam	Benzodiazepine / Seizure rescue	0.5 mg/kg rectal gel (Diastat); max 20 mg	Established pediatric seizure rescue; rectal gel (Diastat) prefilled for home use; onset 5–10 min; prescribe alongside buccal midazolam — both medications, both routes trained.^[24]
Morphine	Opioid / Pain + Dyspnea	0.05–0.1 mg/kg PO/SQ q4h; concentrated oral solution 20 mg/mL	Pre-prescribe before first respiratory event. Start low, titrate to comfort. Neonatal dose: 0.05 mg/kg q4–6h (longer dosing interval from immature hepatic metabolism). ⚠ Neonatal dosing interval is q4–6h, not q4h — slower metabolism^[43]
Glycopyrrolate	Anticholinergic / Secretions	40–100 mcg/kg/day divided TID-QID PO/SQ	Reduces secretions without CNS effects; preferred over atropine in conscious children; oral and SQ formulations; also reduces GERD-associated drooling.^[43]
Omeprazole	PPI / GERD	1 mg/kg/day divided BID PO/GT	Confirm or initiate at enrollment; GERD is universal in neurologically impaired infants; suspension or capsule contents can be given via GT; twice-daily dosing standard in this population.^[33]
Baclofen	Muscle relaxant / Spasticity	5 mg PO TID (≥2 yr); 2.5 mg PO TID (<2 yr); titrate weekly	For spasticity causing positioning difficulty or discomfort; titrate slowly; ⚠ Do not discontinue abruptly — withdrawal can cause seizures and hyperthermia
Gabapentin	Anticonvulsant / Neuropathic pain	5–10 mg/kg/day divided TID PO/GT; titrate to 30–50 mg/kg/day	Particularly useful for Krabbe disease neuropathic pain and irritability; liquid formulation available; synergistic with clonazepam for Krabbe comfort management; low interaction profile
Midazolam Infusion	Benzodiazepine / Refractory seizures & terminal sedation	0.05–0.1 mg/kg/hr CSCI; titrate to seizure comfort	For end-stage refractory seizure management; continuous subcutaneous infusion via syringe driver; combine with phenobarbital for synergistic effect; the goal at end of life is seizure comfort, not seizure freedom.^[30]
Polyethylene Glycol	Osmotic laxative / Constipation	0.5–1 g/kg/day PO/GT dissolved in water or juice	Safe and effective for constipation in children >6 months; for younger infants: glycerin suppositories; constipation is universal in immobile, neurologically impaired children on anticonvulsants and opioids

🌿 Pediatric Symptom Management Decision Tree

Evidence-based · Pediatric-adapted · Hospice-specific

Select a symptom below to begin

What is the primary symptom to address?

🚨 Comfort Kit Must-Haves for Pediatric Life-Limiting Conditions

Buccal midazolam (compounded 2.5–5 mg/mL solution, syringe, written instructions) — home seizure rescue. Rectal diazepam (Diastat, weight-appropriate dose) — backup seizure rescue. Morphine concentrated oral solution (20 mg/mL, syringe for buccal/GT dosing) — dyspnea and pain. Glycopyrrolate (oral solution or SQ) — secretions. Acetaminophen (infant/child liquid) — mild pain and fever. Ondansetron ODT (weight-appropriate dose) — nausea. All medications labeled, dosed by weight, with written instructions posted in the home. The crisis that occurs when the medication is not in the home is a preventable failure.

S11Clinician

Clinician Pointers

High-yield clinical pearls for the pediatric hospice team. The things not in the textbook — learned beside the smallest beds.

1

Prescribe the home rescue seizure protocol before leaving the first visit

Both rectal diazepam AND buccal midazolam. Both. Not one. Train both techniques before you leave. Post the written instructions on the refrigerator. Document the training. The seizure that sends a comfort-directed child to the emergency department because the rescue kit was not assembled is a clinical failure that the family will remember.^[22]

2

Use the child's name at every encounter, in every document, in every conversation

The parent whose child's name is used by the clinical team reports feeling that their child has been recognized as a person rather than a diagnosis. The clinical documentation that refers to "the patient" rather than "Sophia" has failed the family in a specific and documented way. Pull the name from the first moment of contact and use it without hesitation.

3

Establish the individual behavioral comfort indicators at enrollment

Ask the caregiver: "Tell me what it looks like when the baby is uncomfortable or in pain." Document those specific indicators. Use the FLACC or N-PASS scale as the systematic framework, but the parent who has been beside this child every day for six months knows more about that child's behavioral communication than any standardized scale. Build the comfort assessment from what the parent tells you.^[38]

4

Ask about memory-making at the first visit — not the third

"I want to make sure we have the opportunity to create some things that will matter to you in years to come — photographs, handprints, recordings. I would like to offer all of these now while there is time. Is there anything you particularly want to have?" Offer Now I Lay Me Down to Sleep photography. Offer heartbeat recordings. Offer molds of hands and feet. The parent who does not know to ask will not ask until it is too late.^[55]

5

Assess the siblings at enrollment and connect the family to sibling grief resources

Ask the parents: "How are the other children in the family understanding what is happening?" Ask: "Would it be helpful to have some resources for talking with the children about this?" Provide specific age-appropriate resources before the death rather than after. The Dougy Center, child life specialists, and sibling-specific grief programs exist for this purpose.^[53]

6

Complete the birth plan before delivery and distribute it

For prenatally diagnosed conditions: the birth plan is the primary clinical document. It goes in the obstetric chart, the neonatal chart, and the hospice chart. It specifies who holds the baby, resuscitation preferences, comfort medications, memory-making, spiritual care. The birth plan that is completed but not distributed to the delivery team is useless.^[46]

7

Prepare the family for what the death will look like — before it happens

Describe the breathing changes (Cheyne-Stokes, apnea, agonal breathing); the color changes (mottling, cyanosis); the decreased responsiveness. Use plain language: "The breathing will change — it will become irregular, with pauses that get longer. This is the body's natural process of shutting down. It does not mean your baby is struggling." Families who are prepared report less traumatic grief than families who are ambushed by the physical reality of death.^[43]

8

Address the subsequent pregnancy question when the family is ready

For autosomal recessive conditions: recurrence risk is 25%. Genetic counseling, carrier testing for extended family, and reproductive options (PGD, prenatal diagnosis, donor gametes) are part of the comprehensive care plan. This conversation does not diminish the dying child — it honors the family's future. Raise it gently: "When you are ready, we can connect you with genetic counseling to discuss what this means for future pregnancies."^[61]

9

Monitor your own grief as a clinician

The death of a child affects the clinical team differently than the death of an adult. Cumulative grief, vicarious trauma, and burnout are documented in pediatric palliative care at rates higher than in adult hospice. Debrief after every pediatric death. Access supervision and support. The clinician who is emotionally depleted cannot be present for the next family. Taking care of yourself is not optional — it is clinical infrastructure.

10

Call the family after the death — at 48 hours, at 2 weeks, and at the anniversary

The bereavement follow-up call is not a formality. It is a clinical act. The family whose hospice nurse calls them by name, who says the child's name, who asks how they are doing — that family reports feeling that their child mattered to someone beyond the family. The anniversary call is the most powerful: "I wanted you to know that I remember Sophia, and I remember your family."

From the Field

Waldo Rios, NP

Hospice NP · 12+ Years

"Every pediatric case I have ever done has changed me. Not in a soft, sentimental way — in a clinical way. It made me faster with the rescue meds. It made me more precise with the comfort assessment. It made me more direct with the family about what is coming. And it made me understand that using a child's name is not a nice gesture — it is a clinical intervention that changes the entire dynamic of the encounter."

— Waldo, NP

S12EveryoneClinician

Psychosocial & Spiritual Care

The inversion of the natural order — a parent planning a child's death. The grief that began at diagnosis. The siblings. The extended family. The subsequent pregnancy question.

The Inversion of the Natural Order

The death of a child violates the fundamental natural expectation that children outlive their parents. The grief of anticipatory parental bereavement does not have a cultural script. There are very few narratives in human culture that prepare a person to plan their child's death. The parent of a child with a life-limiting condition is navigating a grief that most of the people around them cannot comprehend and for which most social support structures are not designed.^[51]

The hospice chaplain who simply sits with this grief — who does not try to reframe it, who does not offer easy spiritual solutions, who witnesses the full weight of what it means to plan a child's death — provides companionship that is specific to this experience. The clinical response is not to fix the grief. It is to be present with it.^[52]

The Relationship with a Non-Typical Child

The Tay-Sachs child who has developmental regression, the trisomy 18 infant who has complex medical needs but who turns toward the parent's voice, the SMA infant who cannot move but who tracks the parent's face with their eyes — these children have relational lives that exist alongside their medical complexity. The parent who is waiting for the child to "wake up" or "respond normally" may be missing the relational life the child is offering within the constraints of their condition.^[17]

The hospice chaplain or social worker who asks "Tell me about what your baby responds to — what does she seem to enjoy?" opens a conversation about the child's relational life that honors who the child is rather than what the condition has taken.

The Grief That Began at Diagnosis

Anticipatory Grief — Continuous, Not Staged

Grade B

The anticipatory grief of a life-limiting genetic diagnosis begins at the moment of diagnosis and continues through the child's entire life and through the entire bereavement period. It is not a phase — it is a continuous presence. The parent who received the trisomy 18 diagnosis at the 20-week scan has been grieving for weeks or months before the baby is born and before hospice enrollment begins. The hospice team enters a grief already in progress.^[51]

Screen for complicated grief risk factors at enrollment: prior pregnancy loss, mental health history, inadequate social support, traumatic delivery experience
Refer to perinatal grief counseling — this is a specialty; general grief counselors may not be equipped for the specific dynamics of parental bereavement for a child with a genetic condition

Bereavement After a Child's Death

Parental grief duration: Research consistently shows that parental grief after a child's death is more intense and more prolonged than grief after any other type of loss; parents remain at elevated risk for complicated grief, depression, and PTSD for years after the child's death^[52]
Marital impact: The death of a child places significant strain on the parental relationship; couples grieve differently and asynchronously — one parent may be functional while the other is immobilized; normalize this and provide couples resources
The empty nursery: The practical question of what to do with the baby's room, the clothes, the equipment — these are clinical decisions that the bereavement team should anticipate and address

Sibling Grief

Children grieve differently than adults — and they grieve at a developmental level that the adults around them may not recognize as grief. The 3-year-old who is acting out, the 5-year-old who suddenly wets the bed, the 8-year-old who becomes the "perfect child" to avoid adding to the parents' burden — these are all grief responses. The sibling who watches the parent cry and absorbs the message that their home is a place of sadness will carry this into their adult attachment patterns.^[53]

Sibling support is not optional. It is a clinical responsibility. The Dougy Center model, child life specialist engagement, and age-appropriate grief resources should be offered at enrollment — not at the death, not at bereavement. The sibling who is included in the care of the dying baby — who helps with the handprints, who holds the baby with supervision, who is told the truth in age-appropriate language — has better outcomes than the sibling who is excluded and confused.^[54]

Extended Family & Memory-Making

Extended Family Dynamics

Grandparents: Grieve doubly — for the grandchild and for their own child's pain; may have different beliefs about treatment decisions; may need separate support and communication
Cultural and religious community: Some communities have rituals and support structures for child death; others have none; the hospice chaplain can bridge this gap
Friends and peers: The parents' peer group typically has no experience with child death; well-meaning but hurtful comments ("at least you didn't get to know the baby very long"; "you can have another one") are common; the clinical team can provide the family with language to use with their community

Memory-Making as Clinical Intervention

Professional photography: Now I Lay Me Down to Sleep provides free professional photography for families experiencing infant loss — refer at enrollment; the photographs become the most valued possessions the family owns^[55]
Physical mementos: Handprints and footprints (ink or clay); hair clippings; blankets and clothing that carry the baby's scent; recordings of heartbeat (apps available); videos of the baby being held
Evidence base: Radestad et al. demonstrated that memory-making in perinatal loss — specifically, having and holding photographs and mementos — is associated with reduced complicated grief and improved long-term bereavement outcomes^[56]

Subsequent Pregnancy

For autosomal recessive conditions (Tay-Sachs, Krabbe, SMA, Pompe), recurrence risk is 25% for each subsequent pregnancy. The subsequent pregnancy question is one that the family will face — whether at 6 months, at 2 years, or at 5 years after the child's death. The hospice and palliative care team has a role in preparing the family for this conversation and connecting them with genetic counseling, preimplantation genetic diagnosis (PGD), prenatal diagnosis options, and the emotional complexity of becoming pregnant again after losing a child to a genetic condition.^[61]

The subsequent pregnancy carries its own specific grief — the hypervigilance, the anxiety at every ultrasound, the comparison with the previous pregnancy. Perinatal mental health support is indicated for every subsequent pregnancy after a child's death from a genetic condition.

Clinical Pearl

"The chaplain who walks into the room of a parent whose child is dying does not bring answers. The chaplain brings presence. The most powerful spiritual intervention in pediatric palliative care is the willingness to sit in the silence and not look away. The parent who has someone beside them who is not afraid of their pain reports, years later, that that presence was the thing that kept them from falling apart entirely."

S13FamilyEveryone

Family Guide

Plain language for families. Share, print, or read aloud at the bedside. Seizure rescue, feeding, memory-making, sibling support, and when to call.

You are here because your child has been diagnosed with a condition that will limit their life. We know that nothing we say changes that reality. What we can do is make sure that every moment your child has is as comfortable and peaceful as possible, and that your family has the support you need — not just for your child, but for you, for your other children, and for everyone who loves this baby. You are not alone in this. We are beside you.

🔴 About the Seizures — Your Home Rescue Plan

A seizure looks frightening. Knowing what to do makes the difference between managing it at home and a frightening rush to the emergency department.
THE PLAN: Stay calm. Time the seizure. Position your baby on their side. Do not put anything in their mouth.
If the seizure lasts more than 2–3 minutes: Give the rescue medication. Your hospice team has shown you how to give the buccal midazolam (into the cheek) or the rectal diazepam (Diastat). Use whichever one you are most comfortable with.
Buccal midazolam technique: Draw up the prescribed dose. Place the syringe tip between the cheek and the lower gum. Squeeze half the dose on one side, then the other side. The baby does not need to swallow it — it absorbs through the cheek.
After giving the rescue medication: Call the hospice nurse immediately. Stay with your baby. Most seizures will stop within 5–10 minutes after the rescue medication.
If the seizure continues for 10 minutes after the rescue medication: Follow the plan your hospice team has discussed with you — this is in your advance directive.
The rescue medications are at [specific location in the home]. They are labeled. Do not use them for anything else.

🍼 The Feeding — What We Know and What We Believe

Your child may have difficulty swallowing safely. The tube in their stomach (if present) provides the nutrition their body needs.
The question of whether to also give small amounts by mouth belongs to you, not to us. Here is what we know medically: giving small amounts by mouth carries some risk that food or liquid can go into the lungs.
Here is what we also know: The act of feeding your child — the closeness, the connection, the ritual of it — is one of the most important things you can give them, and it is one of the most important things they can receive from you.
If you would like to continue small amounts of oral feeding as a comfort and connection practice — not as nutrition, but as care — we will support that choice. We will show you how to do it as safely as possible: small volumes, slow pacing, upright positioning, and stopping if your baby shows any sign of distress.
If you choose to stop oral feeding, that is also a valid and loving choice. You are not abandoning your child. You are protecting them from discomfort.

📸 Memory-Making — Things That Will Matter Forever

Photographs: Professional photographers from Now I Lay Me Down to Sleep provide free sessions for families like yours — ask your hospice team to arrange this. Also take your own photos — in your arms, with siblings, with grandparents.
Handprints and footprints: Ink or clay — we can help you make these. They will become one of your most treasured possessions.
Recordings: Record your baby's heartbeat on your phone (apps are available). Record yourself singing to your baby. Record the sounds of your family being together.
Clothing and blankets: Keep the blankets and clothing your baby has worn. They carry the baby's scent and the warmth of their body.
Do not wait. If there is something you want to have — a specific photograph, a specific item — tell your hospice team today. We will make it happen.

👧 Your Other Children — Sibling Support

Your other children know something is wrong. Even very young children sense the sadness, the disruption, the parents' tears. They deserve honest, age-appropriate information.
For children under 3: They need routine, physical affection, and the reassurance that their parent is still present for them. Simple language: "The baby is very sick. The doctors are helping."
For children 3–6: They may think they caused the illness. Reassure them directly: "This is not your fault. Nothing you did made the baby sick." Include them if they want to be included — holding the baby, helping with care.
For children 7+: They can understand more. Be honest: "The baby has a condition that means they will not live a long time. We are making sure the baby is comfortable and loved."
Resources: Ask your hospice team about child life specialists and sibling grief groups. The Dougy Center (dougy.org) has excellent resources for children of all ages.

📞 Call the hospice nurse immediately if you see:

A seizure lasting more than 5 minutes that does not respond to the rescue medication. A sudden change in breathing — breathing stops for a long time, or breathing becomes very fast and labored and does not improve with positioning. Your child appears to be in pain — crying that is different from usual, arching, facial grimacing — and the comfort measures you have been taught are not helping. Bleeding from the mouth, nose, or any site that does not stop with gentle pressure. You feel frightened or overwhelmed and need someone with you. This last one is real — you do not need a medical reason to call. We are here for you, not just for your child.

🙏 You are doing something that no parent should ever have to do, and you are doing it with a courage that you may not recognize in yourself right now. Your child knows your voice, your touch, your presence. Research tells us that children who have their family beside them — talking, singing, holding — experience less distress and more comfort. You are not just watching. You are part of the care team. You are the most important part.

S14Everyone

Waldo's Top 10 Tips

Clinical field wisdom from 12+ years at the bedside. The things you learn beside the smallest beds. Not guidelines — real.

01
Use the child's name in every sentence, in every document, in every conversation. Not "the patient," not "the baby," not "the trisomy 18 infant." The parent who hears the clinical team use their child's name reports feeling, in a way they almost cannot articulate, that their child has been recognized as a full person. The clinical documentation that refers to "Sophia" throughout the care plan is a dignity act. I pull the name from the first moment of contact and I use it without hesitation. Every time. The name is not a courtesy — it is a clinical intervention that changes the entire dynamic of the relationship between the family and the team.
02
Prescribe both rescue seizure medications before you leave the first visit. Rectal diazepam AND buccal midazolam. Both. Not one. Because the family needs both to feel prepared, because some families are more comfortable with the buccal route and some with the rectal, and because the seizure that occurs when one medication is not available is a crisis that the other could have managed. I train both techniques before I leave. I post the instructions on the refrigerator. I document the training. The seizure that sends a comfort-directed child to the emergency department because the rescue kit was not assembled is a clinical failure. I have seen it happen. I will not let it happen on my watch.
03
Ask the parents what their child responds to before you perform any clinical assessment. "Before I look at anything clinical, I want to understand who she is. What does Sophia respond to? What seems to bring her comfort? What does it look like when she is unhappy?" The parent who has been beside this child every day for six months knows more about that child's behavioral communication than any standardized scale. I build the comfort assessment from what the parent tells me. I document the specific behavioral comfort indicators for this child as a permanent clinical record. And then I use them at every visit. The parent who sees that I remember their child's specific comfort cues feels that I know their child — not just the diagnosis.
04
Ask about memory-making at the first visit, not the third. The parent who has two weeks with their baby and who does not learn about Now I Lay Me Down to Sleep photography until day 10 has lost time that cannot be recovered. I offer everything at the first visit: photographs, handprints, footprints, heartbeat recordings, clay molds, hair clippings, blankets that carry the baby's scent. Some families want all of it. Some want none of it yet. But the offer is made, the resources are documented, and the family knows that when they are ready, everything is available. I have never had a bereaved parent say "I wish we had fewer memories." I have had many say "I wish we had started sooner."
05
The feeding conversation is the most emotionally loaded conversation in pediatric palliative care and you must hold it with extraordinary care. When a parent asks "should I keep feeding the baby by mouth?" they are not asking a medical question. They are asking "am I still allowed to be a parent?" The answer is always yes. Comfort oral feeding — small amounts, for connection, not for nutrition — is a legitimate clinical prescription. I describe it exactly that way: "You may offer small amounts for comfort and closeness. This is not nutrition — this is love. We will show you how to do it safely." The parent who can still feed their child, even in tiny amounts, retains the most fundamental parenting act. Protecting that act is one of the most important things I do.
06
Pre-prescribe the morphine before the first respiratory event — not during it. The infant with trisomy 18 whose first episode of respiratory distress occurs at 2 AM should not require a call to the on-call physician, a new prescription, and a pharmacy run while the parents watch their baby struggle. The morphine should already be in the home, labeled, with written instructions, from the day of enrollment. I write the prescription at the first visit: morphine concentrated oral solution 0.05–0.1 mg/kg q4h PRN for dyspnea or pain. The parents know where it is. The on-call nurse knows it is available. The crisis that is managed at the bedside in 10 minutes would have been an ambulance ride and an ED visit without it.
07
Do not use the phrase "incompatible with life" in any clinical conversation. Ever. This language was used for decades to describe trisomy 13 and trisomy 18, and it was used to discourage intervention, to justify withholding cardiac surgery, and to foreclose parental choice. The lived experience of families — the children with trisomy 18 who survived years, who went to school, who had relationships — has made this language clinically inaccurate and ethically untenable. The language I use is: "Most children with this condition have a significantly shortened life — but we cannot predict with certainty how long your child will live, and we will not make that prediction foreclose your choices." Hold the data. Hold the uncertainty. Do not use language that eliminates hope.
08
The siblings need you too — and they need you at enrollment, not at bereavement. The 3-year-old who is watching their parent cry every day, who is being shuffled between grandparents, who is told "the baby is sick" but nothing else — that child is accumulating grief without any tools to process it. I assess the siblings at the first visit. I ask the parents: "How are the other kids doing with all this?" I provide age-appropriate resources. I connect the family to child life specialists. The sibling who is included in the care — who helps with the handprints, who is allowed to hold the baby, who is told the truth — does better than the sibling who is excluded and confused. The research is clear on this. Do not wait.
09
Prepare the family for what the death will look like. In specific, concrete, visual language. Before it happens. "When the time comes close, the breathing will change — it will become irregular, with long pauses. The skin color will change — you may see mottling on the knees and feet. These changes are normal. They mean the body is slowing down. They do not mean your baby is in pain." The family who has been prepared for the physical reality of death experiences less traumatic grief than the family who is blindsided by it. I describe what death looks like in plain language, at a visit before the final hours, so the parents can process the information while they still have emotional bandwidth. I never spring it on them at the deathbed.
10
After the death, call the family. At 48 hours. At 2 weeks. At the anniversary. Use the child's name. Say: "I wanted you to know that I remember Sophia, and I remember your family, and I think about you." This is not a formality. This is the clinical act that completes the relationship. The parent who hears their child's name spoken by someone outside the family — months after the death — reports feeling that their child's life mattered beyond their own walls. I have made these calls for 12 years. They are 90 seconds long. They are the most important 90 seconds in bereavement care. The world moves on after a child dies. The parents do not. Be the person who does not move on.

— Waldo, NP

REFClinician

References

Peer-reviewed citations organized by clinical category. Based on articles retrieved from PubMed. All PMIDs hyperlinked. Evidence levels assigned by study design.

Epidemiology & Natural History of Life-Limiting Congenital Conditions

1

Hain R, Devins M, Hastings R, Noyes J. Paediatric palliative care: development and pilot study of a 'Directory' of life-limiting conditions. BMC Palliativ Care. 2013;12:43.

PMID 24330676Observational

2

Fraser LK, Miller M, Hain R, et al. Rising national prevalence of life-limiting conditions in children in England. Pediatrics. 2012;129(4):e923-e929.

PMID 22412035Observational

3

Rasmussen SA, Wong LY, Yang Q, May KM, Friedman JM. Population-based analyses of mortality in trisomy 13 and trisomy 18. Pediatrics. 2003;111(4):777-784.

PMID 12671111Observational

4

ACT (Association for Children's Palliative Care). A Guide to the Development of Children's Palliative Care Services. ACT/RCPCH. 2009;3rd edition.

Guideline

5

Carey JC. Perspectives on the care and management of infants with trisomy 18 and trisomy 13: striving for balance. Curr Opin Pediatr. 2012;24(6):672-678.

PMID 23042250Review

6

Supalat M, Borkenhagen D, Topalovski M. Estimated prevalence of life-limiting conditions in children: a systematic review. J Paediatr Child Health. 2021;57(12):1898-1906.

PMID 34748683Systematic Review

Trisomy 13 & 18 Clinical Management

7

Kosho T, Kuniba H, Tanikawa Y, Hashimoto Y, Sakurai H. Natural history and parental experience of children with trisomy 18 based on a questionnaire given to a Japanese trisomy 18 parental support group. Am J Med Genet A. 2013;161A(7):1531-1542.

PMID 23720410Observational

8

Nelson KE, Rosella LC, Mahant S, Guttmann A. Survival and surgical interventions for children with trisomy 13 and 18. JAMA. 2016;316(4):420-428.

PMID 27458947Observational

9

Kaneko Y, Kobayashi J, Yamamoto Y, et al. Intensive cardiac management in patients with trisomy 13 or trisomy 18. Am J Med Genet A. 2008;146A(11):1372-1380.

PMID 18412104Observational

10

Guon J, Wilfond BS, Palendaz B, Feudtner C. Our children are not a diagnosis: the experience of parents who continue pregnancy after a prenatal diagnosis of trisomy 13 or 18. Am J Med Genet A. 2014;164A(2):308-318.

PMID 24311540Observational

11

Wilfond BS, Carey JC. Ethical issues in trisomy 18 and trisomy 13: the challenges of reframing "lethal" conditions. Am J Med Genet C Semin Med Genet. 2016;172(3):228-232.

PMID 27558836Review

12

American Academy of Pediatrics, Committee on Bioethics. Ethical controversies in organ donation after circulatory death. Pediatrics. 2013;131(5):e1683-e1690.

PMID 23629621Guideline

Tay-Sachs, Krabbe & Storage Disorder Management

17

Maegawa GH, Stockley T, Tropak M, et al. The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported. Pediatrics. 2006;118(5):e1550-e1562.

PMID 17015493Review

18

Wenger DA, Rafi MA, Luzi P, Datto J, Costantino-Ceccarini E. Krabbe disease: genetic aspects and progress toward therapy. Mol Genet Metab. 2000;70(1):1-9.

PMID 10833326Review

19

Patterson MC, Hendriksz CJ, Walterfang M, Sedel F, Vanier MT, Wijburg F. Recommendations for the diagnosis and management of Niemann-Pick disease type C. Mol Genet Metab. 2012;106(3):330-344.

PMID 22572546Guideline

20

Van den Hout HM, Hop W, van Diggelen OP, et al. The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature. Pediatrics. 2003;112(2):332-340.

PMID 12897283Observational

21

Barranger JA, Cabrera-Salazar MA (eds). Lysosomal Storage Disorders. Springer. 2007.

Review

Seizure Management in Pediatric Palliative Care

22

Scott RC, Besag FM, Neville BG. Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial. Lancet. 1999;353(9153):623-626.

PMID 10030327RCT

23

McMullan J, Sasson C, Pancioli A, Silbergleit R. Midazolam versus diazepam for the treatment of status epilepticus in children and young adults: a meta-analysis. Acad Emerg Med. 2010;17(6):575-582.

PMID 20624135Meta-analysis

24

Appleton R, Macleod S, Martland T. Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children. Cochrane Database Syst Rev. 2008;(3):CD001905.

PMID 18646081Systematic Review

25

Hauer JM, Wolfe J. Supportive and palliative care of children with metabolic and neurological diseases. Curr Opin Support Palliat Care. 2014;8(3):296-302.

PMID 24978855Review

26

Abend NS, Gutierrez-Colina AM, Dlugos DJ. Medical treatment of pediatric status epilepticus. Semin Pediatr Neurol. 2010;17(3):169-175.

PMID 20727485Review

27

Hussain SA, Shinnar S, Engel J Jr. Clonazepam for myoclonic seizures: a systematic review. Epilepsia. 2012;53 Suppl 5:165-170.

PMID 22946728Systematic Review

28

Lux AL, Edwards SW, Hancock E, et al. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months. Lancet Neurol. 2005;4(11):712-717.

PMID 16239177RCT

29

Holsti M, Dudley N, Schunk J, et al. Intranasal midazolam vs rectal diazepam for the home treatment of acute seizures in pediatric patients with epilepsy. Arch Pediatr Adolesc Med. 2010;164(8):747-753.

PMID 20679166RCT

30

Wolfe J, Hinds PS, Sourkes BM (eds). Textbook of Interdisciplinary Pediatric Palliative Care — Seizure Management at End of Life. Elsevier. 2011.

Expert Opinion

Feeding & Nutrition in Pediatric Life-Limiting Conditions

32

Sullivan PB, Lambert B, Rose M, Ford-Adams M, Johnson A, Griffiths P. Prevalence and severity of feeding and nutritional problems in children with neurological impairment: Oxford Feeding Study. Dev Med Child Neurol. 2000;42(10):674-680.

PMID 11085295Observational

33

Rosen R, Vandenplas Y, Singendonk M, et al. Pediatric gastroesophageal reflux clinical practice guidelines (ESPGHAN/NASPGHAN). J Pediatr Gastroenterol Nutr. 2018;66(3):516-554.

PMID 29470322Guideline

34

Palecek EJ, Teno JM, Casarett DJ, Hanson LC, Rhodes RL, Mitchell SL. Comfort feeding only: a proposal to bring clarity to decision-making regarding difficulty with eating for persons with advanced dementia. J Am Geriatr Soc. 2010;58(3):580-584.

PMID 20398123Expert Opinion

35

Samson-Fang L, Butler C, O'Donnell M. Effects of gastrostomy feeding in children with cerebral palsy: an AACPDM evidence report. Dev Med Child Neurol. 2003;45(6):415-426.

PMID 12785443Review

36

Craig GM, Scambler G, Spitz L. Why parents of children with neurodevelopmental disabilities requiring gastrostomy feeding need more support. Dev Med Child Neurol. 2003;45(3):183-188.

PMID 12613774Observational

37

Feudtner C, Nathanson PG. Pediatric palliative care and pediatric medical ethics: opportunities and challenges. Pediatrics. 2014;133 Suppl 1:S8-S12.

PMID 24488543Review

Pain & Comfort Assessment in Non-Verbal Infants

38

Merkel SI, Voepel-Lewis T, Shayevitz JR, Malviya S. The FLACC: a behavioral scale for scoring postoperative pain in young children. Pediatr Nurs. 1997;23(3):293-297.

PMID 9220806Observational

39

Hummel P, Puchalski M, Creech SD, Weiss MG. Clinical reliability and validity of the N-PASS: neonatal pain, agitation and sedation scale. J Perinatol. 2008;28(1):55-60.

PMID 18165830Observational

40

Krechel SW, Bildner J. CRIES: a new neonatal postoperative pain measurement score. Initial testing of validity and reliability. Paediatr Anaesth. 1995;5(1):53-61.

PMID 8521311Observational

41

Hauer JM, Wical BS, Charnas L. Gabapentin successfully manages chronic unexplained irritability in children with severe neurologic impairment. Pediatrics. 2007;119(2):e519-e522.

PMID 17272610Observational

42

Breau LM, Finley GA, McGrath PJ, Camfield CS. Validation of the Non-communicating Children's Pain Checklist — Postoperative Version. Anesthesiology. 2002;96(3):528-535.

PMID 11873023Observational

Opioids & Comfort Medications in Pediatric Palliative Care

43

World Health Organization. WHO Guidelines on the Pharmacological Treatment of Persisting Pain in Children with Medical Illnesses. WHO. 2012.

Guideline

44

Drake R, Frost J, Collins JJ. The symptoms of dying children. J Pain Symptom Manage. 2003;26(1):594-603.

PMID 12850642Observational

45

Collins JJ, Grier HE, Kinney HC, Berde CB. Control of severe pain in children with terminal malignancy. J Pediatr. 1995;126(4):653-657.

PMID 7699549Observational

Perinatal Palliative Care

46

Leuthner SR. Palliative care of the infant with lethal anomalies. Pediatr Clin North Am. 2004;51(3):747-759.

PMID 15157596Review

47

Breeze ACG, Lees CC, Kumar A,"; Missfelder-Lobos HH, Murdoch EM. Palliative care for prenatally diagnosed lethal fetal abnormality. Arch Dis Child Fetal Neonatal Ed. 2007;92(1):F56-F58.

PMID 17056841Observational

48

Catlin A, Carter B. Creation of a neonatal end-of-life palliative care protocol. J Perinatol. 2002;22(3):184-195.

PMID 11948380Guideline

49

Janvier A, Farlow B, Wilfond BS. The experience of families with children with trisomy 13 and 18 in social networks. Pediatrics. 2012;130(2):293-298.

PMID 22826574Observational

50

Wool C. Systematic review of the literature: parental outcomes after diagnosis of fetal anomaly. Adv Neonatal Care. 2011;11(3):182-192.

PMID 21730910Systematic Review

Parental Bereavement & Grief

51

Cacciatore J, Schnebly S, Froen JF. The effects of social support on maternal anxiety and depression after stillbirth. Health Soc Care Community. 2009;17(2):167-176.

PMID 18721401Observational

52

Koopmans L, Wilson T, Cacciatore J, Flenady V. Support for mothers, fathers and families after perinatal death. Cochrane Database Syst Rev. 2013;(6):CD000452.

PMID 23784865Systematic Review

Sibling Grief & Support

53

Nolbris M, Hellström AL. Siblings' needs and issues when a brother or sister dies of cancer. J Pediatr Oncol Nurs. 2005;22(4):227-233.

PMID 15994340Observational

54

Davies B. Shadows in the Sun: The Experiences of Sibling Bereavement in Childhood. Brunner/Mazel. 1999.

Review

Memory-Making & Legacy Interventions

55

Blood C, Cacciatore J. Best practice in bereavement photography after perinatal death: qualitative analysis with 104 parents. BMC Pregnancy Childbirth. 2014;14:189.

PMID 24894262Observational

56

Rådestad I, Surkan PJ, Steineck G, Cnattingius S, Onelöv E, Dickman PW. Long-term outcomes for mothers who have or have not held their stillborn baby. Midwifery. 2009;25(4):422-429.

PMID 18222575Observational

SMA Type 1 in the Gene Therapy Era

57

Finkel RS, Mercuri E, Darras BT, et al. Nusinersen versus sham control in infantile-onset spinal muscular atrophy (ENDEAR). N Engl J Med. 2017;377(18):1723-1732.

PMID 29091570RCT

58

Mendell JR, Al-Zaidy S, Shell R, et al. Single-dose gene-replacement therapy for spinal muscular atrophy (STRIVE). N Engl J Med. 2017;377(18):1713-1722.

PMID 29091557RCT

59

Tizzano EF, Finkel RS. Spinal muscular atrophy: a changing phenotype beyond the clinical trials. Neuromuscul Disord. 2017;27(10):883-889.

PMID 28757310Review

60

Lemke D, Palliative Care Clinical Group. Palliative care and spinal muscular atrophy: a systematic review and clinical practice framework. J Pain Symptom Manage. 2019;58(4):695-713.

PMID 31150745Systematic Review

Genetic Counseling & Recurrence Risk

61

Biesecker BB. Goals of genetic counseling. Clin Genet. 2001;60(5):323-330.

PMID 11903330Review

62

Capitulo KL. Evidence for healing interventions with perinatal bereavement. MCN Am J Matern Child Nurs. 2005;30(6):389-396.

PMID 16260940Review

63

Hoeldtke NJ, Calhoun BC. Perinatal hospice. Am J Obstet Gynecol. 2001;185(3):525-529.

PMID 11568772Review

64

Verlinsky Y, Rechitsky S, Schoolcraft W, Strom C, Kuliev A. Preimplantation diagnosis for Fanconi anemia combined with HLA matching. JAMA. 2001;285(24):3130-3133.

PMID 11427142RCT

terminal2.care content is for educational purposes and is not a substitute for clinical judgment. Based on articles retrieved from PubMed. © Terminal2 | terminal2.care

📝

Private Notes

Session notes — not saved to any server. Clears when you close the tab.

Use this space for visit notes, clinical reminders, or patient-specific observations. This text is stored only in your browser session.